Adlai Nortye Ltd. (ANL)

NASDAQ: ANL · Real-Time Price · USD

1.940

-0.250 (-11.42%)

At close: Mar 28, 2025, 4:00 PM

2.219

+0.279 (14.40%)

After-hours: Mar 28, 2025, 7:50 PM EDT

Adlai Nortye Employees

Adlai Nortye had 127 employees as of December 31, 2023. The number of employees decreased by 2 or -1.55% compared to the previous year.

Employees

127

Change (1Y)

-2

Growth (1Y)

-1.55%

Revenue / Employee

$39,370

Profits / Employee

-$425,709

Market Cap

71.59M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2023	127	-2	-1.55%
Dec 31, 2022	129	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

ANL News

11 months ago - Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024 - GlobeNewsWire
11 months ago - Adlai Nortye Announces First Patient Dosed in Randomized Phase II Clinical Trial of Palupiprant (AN0025) for the Treatment of Locally Advanced Rectal Cancer with Radiation Therapy - GlobeNewsWire
1 year ago - Adlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & Development - GlobeNewsWire
1 year ago - Adlai Nortye Announces Completion of Patient Enrollment in Global Phase III Clinical Trial of Buparlisib (AN2025) in Combination with Paclitaxel for the Treatment of Recurrent or Metastatic HNSCC - GlobeNewsWire
1 year ago - Adlai Nortye Ltd. & Nucleai awarded ESMO 2023 BEST Poster Award - GlobeNewsWire
1 year ago - Adlai Nortye Dives In Nasdaq Debut, As Key Product Faces Hurdles - Seeking Alpha
1 year ago - Adlai Nortye Ltd. Announces Closing of Initial Public Offering - GlobeNewsWire
1 year ago - U.S. IPO Weekly Recap: Holdover Adlai Nortye Leads 4 IPO Week As More Small Deals Enter The Pipeline - Seeking Alpha